Asia
The PharmaBoardroom Asia Pacific collection covers pharmaceutical law and regulation across the region's most significant markets, including China, Japan, India, Singapore, Malaysia, Indonesia, Thailand, Vietnam and South Korea. Each handbook is developed with a leading local law firm and provides country-specific guidance on product registration, pricing and reimbursement, clinical trial requirements, pharmacovigilance, manufacturing and GMP requirements, marketing rules, and intellectual property protection.
Asia Pacific is the world's fastest-growing pharmaceutical region, driven by regulatory modernisation in China and India, the expansion of national health insurance systems, and increasing Western pharma investment in Asian biotech assets. Navigating the region requires country-specific knowledge, as regulatory frameworks, pricing systems, and local partnership requirements vary significantly from market to market.
Browse by country below to find the handbook you need.
